(Q79159017)

English

Effector HIV‐specific cytotoxic T‐lymphocyte activity in long‐term nonprogressors: Associations with viral replication and progression

scientific article published on 01 December 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Effector HIV‐specific cytotoxic T‐lymphocyte activity in long‐term nonprogressors: Associations with viral replication and progression (English)

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

HIV long-term survivors

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

5

object named as

John M Kaldor

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Elizabeth Keoshkerian

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Lesley J. Ashton

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

Danielle G. Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

John B. Ziegler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

John M. Kaldor

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

David A. Cooper

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

Graeme J. Stewart

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

Rosemary A. Ffrench

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556259

20 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14556259

20 March 2024

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjmv.10525

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.10525

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

483-491

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556259%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group

1

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

3

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors

4

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Cytotoxic T-lymphocytes from HIV-infected individuals recognize an activation-dependent, non-polymorphic molecule on uninfected CD4+ lymphocytes

5

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Long-term HIV-1 infection without immunologic progression

6

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations.

7

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

9

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group

10

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

HIV-1-Specific Cytotoxic T-Cell Assays

11

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

12

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity

13

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects

14

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals

15

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo

16

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

18

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Virus-specific CD8+ T-cell memory determined by clonal burst size

20

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

T cell memory. Long-term persistence of virus-specific cytotoxic T cells

21

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

An improved method for the detection of HIV antigen in the blood of carriers

22

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

23

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts

24

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

26

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection

27

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Cytotoxic T-cell memory without antigen

28

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

HIV pathogenesis and long-term survival

29

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Long-Term Human Immunodeficiency Virus Infection in Asymptomatic Homosexual and Bisexual Men with Normal CD4+ Lymphocyte Counts: Immunologic and Virologic Characteristics

30

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipients

32

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

33

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

35

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

36

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Aspects of cytotoxic T cell memory

37

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes

38

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

39

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen

40

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

HLA-peptide tetrameric complexes

41

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

42

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Ad

47

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

48

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group

49

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Anti-HIV Type 1 Cytotoxic T Lymphocyte Effector Activity and Disease Progression in the First 8 Years of HIV Type 1 Infection of Homosexual Men

51

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

CCR2 Polymorphism and HIV Disease

53

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

54

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996

55

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Virus load correlates inversely with the expression of cytotoxic T lymphocyte activation markers in HIV-1-infected/AIDS patients showing MHC-unrestricted CTL-mediated lysis

56

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

57

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group

58

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression

59

1 reference

10.1002/JMV.10525

https://api.crossref.org/works/10.1002/JMV.10525

20 March 2024

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79159017&oldid=2107234244"